Home hover Guidelines hover Expert hover Compare hover Faq hover Submit hover About hover Resources hover Syntheses hover Myngc hover Guidelinematrix hover
Home
Browse Guidelines
Expert Commentaries
Guideline Syntheses
Guideline Matrix
Guideline Resources
Compare Guidelines
Frequently Asked Questions
Submit Guidelines
About
myNGC
Search within:  

Sort results by:      



Filter results by:

1-20 of 107   Next >
 
1.  
Dronedarone for the treatment of non-permanent atrial fibrillation. 2010 Aug. NGC:008064
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
2.  
Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation. 2013 Feb. NGC:009629
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
3.  
Atrial fibrillation: the management of atrial fibrillation. 2006 (revised 2014 Jun). NGC:010473
National Clinical Guideline Centre - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
4.  
5.  
Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation. 2012 Mar. NGC:009077
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
6.  
7.  
8.  
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. 2012 Apr. NGC:009500
European Cardiac Arrhythmia Society - Disease Specific Society; European Heart Rhythm Association - Professional Association; Heart Rhythm Society - Professional Association. View all guidelines by the developer(s)
9.  
Recommendations for antithrombotic agents for the prevention of stroke and systemic embolism in patients with atrial fibrillation. 2012 Jun (revised 2013 Mar). NGC:009802
Canadian Agency for Drugs and Technologies in Health - Nonprofit Organization. View all guidelines by the developer(s)
10.  
14.  
Prevention of stroke. In: Canadian best practice recommendations for stroke care. 2006 (revised 2010 Dec 8). NGC:008611
Canadian Stroke Network - Disease Specific Society; Heart and Stroke Foundation of Canada - Disease Specific Society. View all guidelines by the developer(s)
15.  
Cardiac arrhythmias in coronary heart disease. A national clinical guideline. 2007 Feb (reaffirmed 2011). NGC:005528
Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
17.  
Antithrombotics: indications and management. A national clinical guideline. 1999 Mar (revised Aug 2012; republished 2013 Jun). NGC:009304
Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
19.  
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events. 2005 May (revised 2010 Dec). NGC:008658
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
20.  
Guidelines on oral anticoagulation with warfarin - fourth edition. 2006 Feb (revised 2011 Aug). NGC:008814
British Committee for Standards in Haematology - Professional Association. View all guidelines by the developer(s)
1-20 of 107   Next >